NO20070174L - Preparater og fremgangsmater for forebyggelse og kontroll av insulindindusert hypoglykemi - Google Patents

Preparater og fremgangsmater for forebyggelse og kontroll av insulindindusert hypoglykemi

Info

Publication number
NO20070174L
NO20070174L NO20070174A NO20070174A NO20070174L NO 20070174 L NO20070174 L NO 20070174L NO 20070174 A NO20070174 A NO 20070174A NO 20070174 A NO20070174 A NO 20070174A NO 20070174 L NO20070174 L NO 20070174L
Authority
NO
Norway
Prior art keywords
insulin
preparations
control
prevention
methods
Prior art date
Application number
NO20070174A
Other languages
English (en)
Norwegian (no)
Inventor
Daniel T Green
Robert R Henry
Original Assignee
Diobex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diobex Inc filed Critical Diobex Inc
Publication of NO20070174L publication Critical patent/NO20070174L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20070174A 2004-06-29 2007-01-10 Preparater og fremgangsmater for forebyggelse og kontroll av insulindindusert hypoglykemi NO20070174L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58444904P 2004-06-29 2004-06-29
PCT/US2005/022812 WO2006004696A2 (en) 2004-06-29 2005-06-27 Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Publications (1)

Publication Number Publication Date
NO20070174L true NO20070174L (no) 2007-03-13

Family

ID=35783298

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070174A NO20070174L (no) 2004-06-29 2007-01-10 Preparater og fremgangsmater for forebyggelse og kontroll av insulindindusert hypoglykemi

Country Status (11)

Country Link
EP (1) EP1778266A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008505087A (cg-RX-API-DMAC7.html)
KR (1) KR20070029276A (cg-RX-API-DMAC7.html)
CN (1) CN101001638A (cg-RX-API-DMAC7.html)
AU (1) AU2005260025A1 (cg-RX-API-DMAC7.html)
CA (1) CA2571030A1 (cg-RX-API-DMAC7.html)
IL (1) IL180361A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06014970A (cg-RX-API-DMAC7.html)
NO (1) NO20070174L (cg-RX-API-DMAC7.html)
WO (1) WO2006004696A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700708B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5894174B2 (ja) 2010-11-03 2016-03-23 アレコー リミテッド グルカゴンを含む新規組成物
CA2995392C (en) 2015-09-04 2023-08-15 Hailiang Chen Stabilized glucagon solutions
GB201611077D0 (en) 2016-06-24 2016-08-10 Arecor Ltd Novel composition
US11357829B2 (en) 2017-02-03 2022-06-14 Vanderbilt University Systems, compositions and methods for treating diabetes
JP2020527396A (ja) * 2017-07-14 2020-09-10 ゼリス ファーマシューティカルズ インコーポレイテッド 先天性高インスリン症を処置する方法
WO2019108640A1 (en) * 2017-11-28 2019-06-06 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods and kits for evaluating metabolism
AU2021297529A1 (en) * 2020-06-26 2022-09-22 Xeris Pharmaceuticals, Inc. Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
GB202109087D0 (en) * 2021-06-24 2021-08-11 Norwegian Univ Sci & Tech Ntnu Therapeutic methods and devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897551A (en) * 1971-04-05 1975-07-29 Lilly Co Eli Iodoglucagons and process for prolonging the biological activity of glucagon
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
BR0316327A (pt) * 2002-11-18 2005-09-27 Pfizer Prod Inc Amidas cìclicas fluorinadas inibidoras de dipeptidilpeptidase iv
KR20050086948A (ko) * 2002-12-27 2005-08-30 디오벡스, 인코포레이티드 인슐린으로 인한 저혈당증을 예방하고 조절하기 위한조성물 및 방법

Also Published As

Publication number Publication date
WO2006004696A2 (en) 2006-01-12
EP1778266A2 (en) 2007-05-02
EP1778266A4 (en) 2009-09-09
ZA200700708B (en) 2009-03-25
WO2006004696A3 (en) 2006-10-26
CN101001638A (zh) 2007-07-18
JP2008505087A (ja) 2008-02-21
CA2571030A1 (en) 2006-01-12
IL180361A0 (en) 2007-06-03
KR20070029276A (ko) 2007-03-13
MXPA06014970A (es) 2007-03-07
AU2005260025A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
NO20053537L (no) Preparater og fremgangsmater for forebyggelse og kontroll av insulinindusert hypoglycemi.
NO20070174L (no) Preparater og fremgangsmater for forebyggelse og kontroll av insulindindusert hypoglykemi
Malone et al. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy
NO340679B1 (no) Pyridazinonderivativer, farmasøytiske preparater omfattende slike og slike forbindelser og preparater for anvendelse i terapeutisk aktive substanser til behandling og forebygging av sykdommer
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
WO2009142772A3 (en) Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
PH12021552045A1 (en) Glucose sensitive insulin derivatives
Bader et al. Vildagliptin more effectively achieves a composite endpoint of HbA1c< 7.0% without hypoglycaemia and weight gain compared with glimepiride after 2 years of treatment
MX2009007723A (es) Medicacion basada en exenatida y dalargina para el tratamiento de diabetes mellitus, su uso y modalidad de tratamiento.
Xu et al. Ulinastatin suppresses systemic inflammatory response following lung ischemia-reperfusion injury in rats
TNSN08144A1 (en) Kit for parenteral administration of medicaments
EA201070557A1 (ru) Способы и композиции для замедления набора веса, связанного с применением атипичных антипсихотических препаратов
Mest Dipeptidyl peptidase-IV inhibitors can restore glucose homeostasis in type 2 diabetics via incretin enhancement
EP3758689A4 (en) METHODS FOR THE PREVENTION AND TREATMENT OF HYPOGLYCEMIA IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES
DK1675611T3 (da) Terapeutiske anvendelser for C-peptid
Kulasekararaj et al. Phase 3 study of danicopan, an oral complement factor D inhibitor, as add-on therapy to a C5 inhibitor in patients with paroxysmal nocturnal hemoglobinuria with clinically evident extravascular hemolysis
Kato et al. Distinct pharmacodynamics of insulin glargine and insulin detemir: crossover comparison in type 1 and type 2 diabetic patients on basal-bolus regimen
EA200800338A1 (ru) Профилактика и лечение офтальмологических осложнений диабета
NO20075508L (no) Stannsoporfinpreparater og administrering
NO20075831L (no) Krystallinske faste og amorfe former av (-)- halofenat
MD20060037A (ro) Metodă de tratament al hepatitei virale acute C
Sanchez et al. Variceal bleeding and long-acting octreotide: a new addition to the armamentarium?
Cohn et al. San Antonio vasopressin in shock symposium report
Mascitelli et al. Role of ezetimibe in the prevention of cardiovascular disease: absence of evidence
Xu et al. Acute efficacy of a novel anti-tissue factor pathway inhibitor antibody BAY 1093884 in hemophilia A mouse severe tail bleeding

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application